Lindian Resources Ltd (ASX:LIN, OTC:LINIF) has fully entered construction mode at its flagship Kangankunde Rare Earths ...

The Downstream Processing Market is entering a high-stakes expansion phase driven by surging biopharmaceutical production, intensified demand for monoclonal antibodies, and rapid scale-up of cell and ...

Process intensification has reduced the cost of mAb manufacturing, but tweaks across bioproduction will be needed to reduce ...

Purifying novel therapeutics remains a major challenge as increasingly complex molecules move towards the clinic. With Lonza, you can ensure optimal product quality and bring your molecules to the ...

In this webinar, our speaker will explore a series of practical, chromatography-focused strategies designed to enhance mAb purification performance while reducing cost of goods (COGs).

Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...

This session will explore how integrating Ready Made Solutions can help streamline downstream bioprocessing by reducing complexity and increasing efficiency for MSAT and production teams. Together, ...

Petróleo Brasileiro SA (Petrobras) has signed a contract to sell its 5,800-b/d Unidade de Industrialização do Xisto (SIX) unit—including a mine in one of the world’s largest oil shale reserves and a ...

Biopharmaceutical downstream processing requires precise control of multiple unit operations—from chromatography and filtration to viral inactivation—to ensure product quality and therapeutic efficacy ...

Particle size distribution (PSD) continues to be one of the most decision-critical variables in metal mining, impacting ...

The Downstream Processing Market is entering a high-stakes expansion phase driven by surging biopharmaceutical production, intensified demand for monoclonal antibodies, and rapid scale-up of cell and ...